Leveraging large-scale multi-omics to identify therapeutic targets from genome-wide association studiesSamuel Lessard, Clément Chatelain, Khader Shameer et al.|medRxiv|2023Cited by 4
The Lupus Epigenome Relates to Genetics, Transcription and Serological Profiles with Dependency on Molecular Subtypes and Informs Drug DiscoveryOlivia Castellini-Pérez, Marta E. Alarcón‐Riquelme, Guillermo Barturen et al.|medRxiv|2023Cited by 1
A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samplesVirginia Savova, Emanuele de Rinaldis, Richa Hanamsagar et al.|Research Square|2021Cited by 0
A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samplesRicha Hanamsagar, Virginia Savova, Mathew Chamberlain et al.|medRxiv|2021Cited by 0
A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samplesVirginia Savova, Emanuele de Rinaldis, Richa Hanamsagar et al.|Research Square|2021Cited by 0